 .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07F_AntidiarrhealMicroorganisms.A07FA02_SaccharomycesBoulardii.SaccharomycesBoulardii .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07F_AntidiarrhealMicroorganisms.A07FA02_SaccharomycesBoulardii.SaccharomycesBoulardii| name: | SaccharomycesBoulardii | |
| ATC code: | A07FA02 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 500 | mg |
| volume of distribution: | 1 | L |
| clearance: | 0 | L/h |
| other parameters in model implementation | ||
Saccharomyces boulardii is a probiotic yeast used in the prevention and treatment of gastrointestinal disorders such as antibiotic-associated diarrhea, travelers’ diarrhea, and some forms of infectious diarrhea. It is not a pharmacological drug but a living microorganism that acts by modulating the gut flora and local immunity. It is approved and widely used as an over-the-counter probiotic supplement in many countries.
No classical pharmacokinetic parameters are reported because Saccharomyces boulardii is a living microorganism, not absorbed systemically, and exerts its effects locally in the gastrointestinal tract in both adult and pediatric populations.